Previous close | 43.54 |
Open | 38.40 |
Bid | 40.34 x 0 |
Ask | 0.00 x 0 |
Day's range | 38.23 - 38.85 |
52-week range | 33.78 - 48.18 |
Volume | |
Avg. volume | 158,098 |
Market cap | 10.721B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 32.25 |
EPS (TTM) | 1.35 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
QIAGEN (QGEN) supports the new TB screening guidelines from AAP, recommending IGRA tests like QFT-Plus to screen at-risk children of all ages.
American Academy of Pediatrics in the United States now recommends IGRA tests like QuantiFERON-TB Gold Plus to screen at-risk children of all ages // New recommendation joins trend of U.S. tuberculosis control guidelines that emphasize use of modern blood-based tests to combat the spread of potentially deadly bacterial infectionGermantown, Maryland, and Venlo, the Netherlands, June 27, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it welcomes ne
QIAGEN's (QGEN) latest QCI Interpret release improves the performance of high-throughput NGS labs.